Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill & Intangibles: 2013-2025

Historic Goodwill & Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Sep 2025 value amounting to $629.0 million.

  • Amphastar Pharmaceuticals' Goodwill & Intangibles rose 0.38% to $629.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $629.0 million, marking a year-over-year increase of 0.38%. This contributed to the annual value of $628.6 million for FY2024, which is 0.29% up from last year.
  • Amphastar Pharmaceuticals' Goodwill & Intangibles amounted to $629.0 million in Q3 2025, which was up 0.00% from $628.9 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles peaked at $635.2 million during Q2 2023, and registered a low of $42.9 million during Q3 2022.
  • Moreover, its 3-year median value for Goodwill & Intangibles was $628.6 million (2024), whereas its average is $576.0 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Goodwill & Intangibles decreased by 4.68% in 2022 and then skyrocketed by 1,379.04% in 2023.
  • Quarterly analysis of 5 years shows Amphastar Pharmaceuticals' Goodwill & Intangibles stood at $45.0 million in 2021, then declined by 2.60% to $43.8 million in 2022, then surged by 1,329.79% to $626.8 million in 2023, then grew by 0.29% to $628.6 million in 2024, then grew by 0.38% to $629.0 million in 2025.
  • Its Goodwill & Intangibles stands at $629.0 million for Q3 2025, versus $628.9 million for Q2 2025 and $628.7 million for Q1 2025.